Abstract:Objective To screen a key molecule, leucine-rich glioma inactivated protein 4 (LGI4), which participates in endothelial cell-mediated osteosarcoma metastasis, and to further analyze its function and molecular mechanism in osteosarcoma metastasis. Methods A co-culture model of human umbilical vein endothelial cells (HUVECs)-osteosarcoma cells was established, and the genes with significant fold change were screened by whole transcriptome sequencing in combination with relevant literature. After, the candidate target gene, LGI4 was verified with real-time quantitative PCR (RT-qPCR) and Western blotting, the expression of LGI4 at mRNA and protein levels was also determined. Osteosarcoma cell line 143B and MTF LGI4 were transfected with the overexpression plasmid of LGI4 to construct the cells with stable overexpression of LGI4. Then the experiments included 5 groups of osteosarcoma cells, including negative control group (normally cultured), co-culture group (co-cultured with HUVECs), co-culture medium group (treated with the HUVECs medium), vector control group (transfected with control plasmid) and LGI4 group (overexpression of LGI4). Transwell assay and wound healing test were used to detect the migration and invasion abilities of osteosarcoma cells. A tumor metastasis model in nude mice was used to verify the effect of LGI4 overexpressed osteosarcoma cells on distant metastasis in vivo. Bioinformatics analysis was applied to analyze the potential downstream target signaling pathways of LGI4, and recovery experiments were performed with related inhibitors to clarify the role of target signaling pathways in the regulation of osteosarcoma metastasis by LGI4. Results The expression levels of LGI4 were markedly decreased in 143B and MTF cells after co-culture with HUVECs (P < 0.05). Compared with the negative control group, the cell migration and invasion abilities of the co-culture group and co-medium group were significantly enhanced, whereas the cell migration and invasion rates of the LGI4 overexpression group were significantly lower than that of the vector control group (P < 0.05). The nude mice metastasis model revealed that the metastasis ability of osteosarcoma cells was suppressed with LGI4 overexpression. Further analysis revealed that NOTCH4 signaling pathway was the downstream target signaling pathway of LGI4, and functional recovery experiments confirmed that LGI4 resulted in osteosarcoma metastasis by inhibiting NOTCH4 signaling pathway (P < 0.05). Conclusion Endothelial cells activate NOTCH4 signaling pathway and thus promote tumor metastasis by inhibiting the expression of LGI4 in osteosarcoma cells.

MYLK4 promotes tumor progression through the activation of epidermal growth factor receptor signaling in osteosarcoma

ACSL4 accelerates osteosarcoma progression via modulating TGF-β/Smad2 signaling pathway

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Endothelial Cells Promote Osteosarcoma Cell Metastasis by Inhibiting LGI4 Expression and Activating NOTCH4 Signaling Pathway

Ailanthone Targets the KMT2A-MEN1 Complex to Suppress Lung Metastasis of Osteosarcoma

KLF4 Functions As an Oncogene in Promoting Cancer Stem Cell-Like Characteristics in Osteosarcoma Cells

Promotion of Proliferation and Inhibition of Apoptosis by Diacylglycerol Kinase Zeta, a Potential Oncogene of Osteosarcoma

Low Expression of ZFP36L1 in Osteosarcoma Promotes Lung Metastasis by Inhibiting the SDC4-TGF-β Signaling Feedback Loop

Maternal Embryonic Leucine Zipper Kinase Serves As a Poor Prognosis Marker and Therapeutic Target in Osteosarcoma

Exosomal Transfer of LCP1 Promotes Osteosarcoma Cell Tumorigenesis and Metastasis by Activating the JAK2/STAT3 Signaling Pathway

Tumor-associated Macrophages Promote Lung Metastasis and Induce Epithelial-Mesenchymal Transition in Osteosarcoma by Activating the COX-2/STAT3 Axis.

URG4 Mediates Cell Proliferation and Cell Cycle in Osteosarcoma Via GSK3β/β-catenin/cyclin D1 Signaling Pathway

MACC1 Contributes to the Development of Osteosarcoma Through Regulation of the HGF/c-Met Pathway and Microtubule Stability

Fibulin-4 Promotes Osteosarcoma Invasion And Metastasis By Inducing Epithelial To Mesenchymal Transition Via The Pi3k/Akt/Mtor Pathway

Nectin-4 promotes osteosarcoma progression and metastasis through activating PI3K/AKT/NF-κB signaling by down-regulation of miR-520c-3p

High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma Via the NF-κB Pathway in MG63 Cells.

HER4 Promotes the Growth and Metastasis of Osteosarcoma Via the PI3K/AKT Pathway.

KDM6B-mediated histone demethylation of LDHA promotes lung metastasis of osteosarcoma

Effect of activation of the Akt/mTOR signaling pathway by EEF1A2 on the biological behavior of osteosarcoma

Epidermal Growth Factor Receptor Promotes Tumor Progression and Contributes to Gemcitabine Resistance in Osteosarcoma.

Deciphering possible mechanisms of action in pathophysiology of osteosarcoma: PI3K-Akt/MAPK pathways contribute to tumorigenesis versus FoxO/mTOR/HIF-1 pathways involved in metastasis.